Adjuvant and Formulation Considerations for a Subunit Blood-Stage Malaria Vaccine

22 Pages Posted: 14 Jun 2019

See all articles by Martin Chang

Martin Chang

Georgia State University, College of Law; University of Hawaii at Manoa

Date Written: August 15, 2012

Abstract

Protection against malaria from a vaccine requires modulation of the immune response to malaria antigens. This modulation by pathogen-derived molecules is explored in this study. Human immune cells synergistically express signaling proteins when stimulated by certain combinations of pathogen-derived molecules. Some of these expression profiles indicate a Th1-mediated immune response, which may be the immune response needed for the next-generation malaria of vaccines, in terms of effectiveness.

Keywords: malaria, vaccine, public health

Suggested Citation

Chang, Martin and Chang, Martin, Adjuvant and Formulation Considerations for a Subunit Blood-Stage Malaria Vaccine (August 15, 2012). Available at SSRN: https://ssrn.com/abstract=3397972 or http://dx.doi.org/10.2139/ssrn.3397972

Martin Chang (Contact Author)

University of Hawaii at Manoa

NA
United States

Georgia State University, College of Law ( email )

Atlanta, GA
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
28
Abstract Views
405
PlumX Metrics